GSK3B and liver dysplastic nodule: In conclusion, ginsenoside Rg1 inhibits podocyte EMT by inducing autophagy via regulation of the AKT/GSK3β/β-catenin pathway, providing a reasonable basis for its therapeutic use in DN.